Difference between revisions of "PCC TC Face to Face July 22 26, 2019 Minutes"

From IHE Wiki
Jump to navigation Jump to search
Line 52: Line 52:
 
***C-01 to C-03, C-05 to C-10: persuasive
 
***C-01 to C-03, C-05 to C-10: persuasive
 
***C-04: non persuasive
 
***C-04: non persuasive
 +
 +
*'''IPS-International Patient Summary (Profil proposal)'''
 +
**Attendees: same +
 +
***In Person: Lori Fourquet, Tone Southerland (IQVIA)
 +
***Via Webex: Michael Nusbaum

Revision as of 08:22, 23 July 2019

Monday July 22, 2019

  • Attendees
    • In Person: Michael Clifton (Epic), Tone Southerland (IQVIA), Thierry Dart (ASIP Santé)
    • Via Webex: Emma Jones (Allscripts)
  • Review Anti-trust and Patent Policy
  • Format codes
    • Format codes IHE and HL7 have their own format codes
    • There is a lot of confusion for a vendor perspective between format codes and template ID
      • Shall PCC work on a profile to manage this ?
  • DCP and CDA-DSS (review of public comments)
    • Collect of all comments has been done by Emma Jones.
    • Comments will be reviewed on Tuesday
    • DCP : 3 types of comments have been received of comments [1]
    • CDA-DSS : comments have been received from Steve [2]


  • IPS-International Patient Summary (Profil proposal)
    • Website [3]
    • Attendees: same +
      • In Person: Lori Fourquet, Derek,
      • Via Webex: Michael Nusbaum
    • IHE PCC TC questions
      • 1)Scope of workflow
      • 2)Benefits for vendor (risks
      • 3)Marketing
    • Next steps
      • IHE PCC TC needs more detail about this proposal.
      • Is there any additional stake holder ?
      • Who is responsible of what (HL7/IHE)?

Tuesday July 23, 2019

  • Attendees
    • In Person: Michael Clifton (Epic), Thierry Dart (ASIP Santé)
    • Via Webex: Emma Jones (Allscripts)
  • DCP and CDA-DSS (review of public comments)
    • DCP public comments
      • C-01 to C08, C-10 to C-12, C-15 to C-16, C-19 to C-46: Persuasive
      • C-09, C-13, C-14, C-18, C-46: Emma needs input from Jeff
      • C-47, C-48: Non persuasive
      • C-49, C-52: Hold for now
      • C-02: Persuasive, Content modules in PCC are in Volume 2, should be Appendix D
      • C-25 to C-28: persuasive, split the use cases to simplify the diagram to include the additional subscribe transactions
    • CDA-DSS public comments
      • C-01 to C-03, C-05 to C-10: persuasive
      • C-04: non persuasive
  • IPS-International Patient Summary (Profil proposal)
    • Attendees: same +
      • In Person: Lori Fourquet, Tone Southerland (IQVIA)
      • Via Webex: Michael Nusbaum